» Articles » PMID: 20404514

Dietary N-3 Polyunsaturated Fatty Acids Fail to Reduce Prostate Tumorigenesis in the PB-ErbB-2 X Pten(+/-) Preclinical Mouse Model

Abstract

Diet and obesity, and their associated metabolic alterations, are some of the fastest-growing causes of disease and death in America. Findings from epidemiological studies correlating obesity, the sources of dietary fat and prostate cancer (PCa) are conflicting. We have previously shown that 15% of PB-ErbB-2 x pten(+/-) mice developed PCa and exhibited increased phosphorylated 4E-BP1, but not the key PI3-kinase intermediary phospho-protein, mTOR, when maintained on unrefined mouse chow. We report herein that 100% of animals fed refined, westernized AIN-93-based diets containing corn oil developed PCa by 12 months of age. Increases in visceral fat and mTO R activation in the tumors were also observed. Furthermore, nuclear cyclin E levels were significantly induced by the AIN-93-corn oil-based diets versus chow. Replacing 50% of the corn oil with menhaden oil, with 21% of its triglycerides being n-3 PUFA's, had no effect on tumorigenesis, fat deposition, cyclin E or mTOR. Phosphorylated BAD levels were similar in the tumors of mice in all three diets. Our data demonstrated that in the context of our preclinical model, components of crude chow, but not dietary n-3 PUFAs, protect against PCa progression. In addition, these data establish phosphorylated mTOR, nuclear cyclin E and visceral fat deposits as possible biomarkers of increased dietary risk for PCa.

Citing Articles

Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.

Lu C, Mahajan A, Hong S, Galli S, Zhu S, Tilan J Nat Commun. 2022; 13(1):2323.

PMID: 35484119 PMC: 9051212. DOI: 10.1038/s41467-022-29898-x.


Dietary palmitate cooperates with Src kinase to promote prostate tumor progression.

Kim S, Yang X, Yin A, Zha J, Beharry Z, Bai A Prostate. 2019; 79(8):896-908.

PMID: 30900312 PMC: 6502658. DOI: 10.1002/pros.23796.


Manganese-Enhanced Magnetic Resonance Imaging as a Diagnostic and Dispositional Tool after Mild-Moderate Blast Traumatic Brain Injury.

Rodriguez O, Schaefer M, Wester B, Lee Y, Boggs N, Conner H J Neurotrauma. 2015; 33(7):662-71.

PMID: 26414591 PMC: 4827293. DOI: 10.1089/neu.2015.4002.


High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases.

Hong S, Tilan J, Galli S, Izycka-Swieszewska E, Polk T, Horton M Oncotarget. 2015; 6(9):7151-65.

PMID: 25714031 PMC: 4466675. DOI: 10.18632/oncotarget.3345.


Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI.

Sirajuddin P, Das S, Ringer L, Rodriguez O, Sivakumar A, Lee Y Cell Cycle. 2012; 11(20):3801-9.

PMID: 22983062 PMC: 3495823. DOI: 10.4161/cc.21988.


References
1.
Kane C, Bassett W, Sadetsky N, Silva S, Wallace K, Pasta D . Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE. J Urol. 2005; 173(3):732-6. DOI: 10.1097/01.ju.0000152408.25738.23. View

2.
Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi P . Pten is essential for embryonic development and tumour suppression. Nat Genet. 1998; 19(4):348-55. DOI: 10.1038/1235. View

3.
Chavarro J, Stampfer M, Hall M, Sesso H, Ma J . A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality. Am J Clin Nutr. 2008; 88(5):1297-303. PMC: 2843087. DOI: 10.3945/ajcn.2008.26419. View

4.
Ritch C, Wan R, Stephens L, Taxy J, Huo D, Gong E . Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men. J Urol. 2006; 177(1):97-101. DOI: 10.1016/j.juro.2006.08.105. View

5.
Moore T, Beltran L, Carbajal S, Strom S, Traag J, Hursting S . Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues. Cancer Prev Res (Phila). 2009; 1(1):65-76. DOI: 10.1158/1940-6207.CAPR-08-0022. View